Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.26 | N/A |
| PEG Ratio (TTM) | -0.69 | N/A |
| P/S Ratio (TTM) | 0.37 | N/A |
| P/B Ratio (TTM) | 0.92 | N/A |
| P/FCF Ratio (TTM) | 13.27 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.57 | N/A |
| Price to 5YR AVG FCF Ratio | -10.87 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.79% | N/A |
| ROE (TTM) | 7.00% | N/A |
| Net Profit Margin (TTM) | 2.79% | N/A |
| ROIC 5YR AVG | 10.89% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 133.92% | 306.93% | 200.91% |
| Revenue | 4.23% | 5.21% | 4.24% |
| Net Income | 131.85% | 296.08% | 190.21% |
| Cash Flow | 26.84% | -2.86% | -150.66% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.64 | N/A |
| Quick Ratio (TTM) | 0.33 | N/A |
| D/E Ratio (TTM) | 0.86 | N/A |
| Interest Coverage (TTM) | 2.08 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.81 | N/A |
| LTL to 5YR AVG FCF | -12.10 | N/A |
| Shares Outstanding Growth 5YR AVG | -5.34% | N/A |